These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8748215)

  • 1. The diagnostic utility of serum ferritin estimation in Nigerian patients with primary hepatocellular carcinoma.
    Ola SO; Akanji AO; Ayoola EA
    Nutrition; 1995; 11(5 Suppl):532-4. PubMed ID: 8748215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnostic utility of serum ferritin. Estimation in patients with primary hepatocellular carcinoma.
    Ola SO; Akanji AO; Ayoola EA
    Trop Geogr Med; 1995; 47(6):302-4. PubMed ID: 8650746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum alphafoetoprotein, hepatitis B virus infection and primary hepatocellular carcinoma in Nigerians.
    Ola SO; Olubuyide IO; Ayoola EA
    East Afr Med J; 1994 Dec; 71(12):782-3. PubMed ID: 7535684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of hepatitis B and C viral markers in patients with primary hepatocellular carcinoma in Singapore.
    Khin LW; Teo CJ; Guan R
    Singapore Med J; 1996 Oct; 37(5):492-6. PubMed ID: 9046201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of serum ferritin determination for hepatocellular carcinoma.
    Nakano S; Kumada T; Sugiyama K; Watahiki H; Takeda I
    Am J Gastroenterol; 1984 Aug; 79(8):623-7. PubMed ID: 6205585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the clinical characteristics among hepatocellular carcinoma of hepatitis B, hepatitis C and non-B non-C patients.
    Dohmen K; Shigematsu H; Irie K; Ishibashi H
    Hepatogastroenterology; 2003; 50(54):2022-7. PubMed ID: 14696457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features of HBsAg-negative but anti-HBc-positive hepatocellular carcinoma in a hepatitis B virus endemic area.
    Shim J; Kim BH; Kim NH; Dong SH; Kim HJ; Chang YW; Lee JI; Chang R
    J Gastroenterol Hepatol; 2005 May; 20(5):746-51. PubMed ID: 15853989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features of hepatocellular carcinoma seronegative for both HBsAg and anti-HCV antibody but positive for anti-HBc antibody in Japan.
    Yano Y; Yamashita F; Sumie S; Ando E; Fukumori K; Kiyama M; Oyama T; Kuroki S; Kato O; Yamamoto H; Tanaka M; Sata M
    Am J Gastroenterol; 2002 Jan; 97(1):156-61. PubMed ID: 11808941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum ferritin in Nigerian patients with Burkitt's lymphoma and other malignant diseases.
    Bolarin DM
    Acta Trop; 1983 Mar; 40(1):71-7. PubMed ID: 6134456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HBsAg, aflatoxins and primary hepatocellular carcinoma.
    Olubuyide IO; Maxwell SM; Hood H; Neal GE; Hendrickse RG
    Afr J Med Med Sci; 1993 Sep; 22(3):89-91. PubMed ID: 7839921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of transfusion-transmitted virus among patients with non-B, non-C hepatocellular carcinoma.
    Nakagawa N; Ikoma J; Ishihara T; Yasui N; Fujita N; Iwasa M; Kaito M; Watanabe S; Adachi Y
    Cancer; 1999 Oct; 86(8):1437-40. PubMed ID: 10526270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Etiologic fraction and interaction of risk factors for primary hepatocellular carcinoma in Wenzhou, Zhejiang Province].
    Zou CL; Chen ZJ; Jin WY; Ni SC; Chen BF; Hu YL
    Zhonghua Yu Fang Yi Xue Za Zhi; 2003 Sep; 37(5):355-7. PubMed ID: 14680600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of serum ferritin in primary hepatocellular carcinoma.
    Giannoulis E; Arvanitakis C; Nikopoulos A; Doutsos I; Tourkantonis A
    Digestion; 1984; 30(4):236-41. PubMed ID: 6210220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevalence of HCV and HBV infection in patients with primary hepatocellular carcinoma in Shanxi Province].
    Wang J; Zhao H; Zhao S
    Zhonghua Liu Xing Bing Xue Za Zhi; 1999 Aug; 20(4):215-7. PubMed ID: 10682498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical and etiologic features of hepatocarcinoma in Sicily].
    Carroccio A; Soresi M; Bonfissuto G; Magliarisi C; Anastasi G; Vuturo O; Notarbartolo A; Montalto G
    Ann Ital Med Int; 1999; 14(4):233-8. PubMed ID: 10638015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications of serum basic fibroblast growth factor levels in chronic liver diseases and hepatocellular carcinoma.
    Hsu PI; Chow NH; Lai KH; Yang HB; Chan SH; Lin XZ; Cheng JS; Huang JS; Ger LP; Huang SM; Yen MY; Yang YF
    Anticancer Res; 1997; 17(4A):2803-9. PubMed ID: 9252719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential tumor markers and hepatitis markers profile in liver tumors.
    Khalifa A; Mady EA; Abadeer N; Kamal A
    Anticancer Res; 1999; 19(4A):2495-500. PubMed ID: 10470181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group.
    Ishii M; Gama H; Chida N; Ueno Y; Shinzawa H; Takagi T; Toyota T; Takahashi T; Kasukawa R
    Am J Gastroenterol; 2000 Apr; 95(4):1036-40. PubMed ID: 10763956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of serum protein fingerprinting coupled with artificial neural network model in diagnosis of hepatocellular carcinoma.
    Wang JX; Zhang B; Yu JK; Liu J; Yang MQ; Zheng S
    Chin Med J (Engl); 2005 Aug; 118(15):1278-84. PubMed ID: 16117882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S; Nakashima Y; Kojiro M; Tabor E
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.